Patent · US Active

Human antibodies to artemin and methods of use thereof

US11926661B2 · kind B2 · utility

0Cited by

7References

27Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Susan D. Croll · New Paltz, US
Lynn Macdonald · Harrison, US
Andrew J. Murphy · Croton-on-Hudson, US

Key dates

Filing date	Apr 19, 2022
Grant date	Mar 12, 2024
Priority date	—
Expiry date	Apr 23, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides antibodies and antigen-binding fragments thereof that bind to human artemin. Methods for using anti-artemin antibodies and antigen-binding fragments are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.